Astec LifeSciences Limited has made a regulatory disclosure under SEBI Listing Regulations Regulation 30 regarding its Employees Stock Option Plan, 2012 (ESOP 2012).

Key Quantitative Figures

  • Number of Equity Shares Allotted: 582 (Five Hundred and Eighty-Two)
  • Face Value per Share: ₹10 (Rupees Ten Only)
  • Exercise Price per Option: ₹10 (Rupees Ten Only)
  • Total Proceeds Realized: ₹5,820 (Rupees Five Thousand Eight Hundred and Twenty Only)

Dates of Action

The committee approval and allotment occurred on 1st June, 2026.

Capital Structure Impact

Post-allotment, the company's total paid-up equity share capital stands at:

  • Amount: ₹22,28,28,200 (Rupees Twenty-Two Crore Twenty-Eight Lakh Twenty-Eight Thousand Two Hundred Only)
  • Number of Shares: 2,22,82,820 (Two Crore Twenty-Two Lakh Eighty-Two Thousand Eight Hundred and Twenty) Equity Shares
  • Face Value: ₹10 per share

The new shares rank pari passu with the existing equity shares of the company.

Authorized Signatory

The disclosure was signed by Tejashree Pradhan, Company Secretary & Compliance Officer (FCS 7167), with digital signature timestamped 2026.06.01 18:58:07 +05'30'.